FDA grants IDE to SpinaFX for study of Triojection
June 10, 2026
The planned trial is expected to include 300 participants across two treatment arms.
The planned trial is expected to include 300 participants across two treatment arms.
The sensor expands Glean into wireless, catheter-free multi-channel urodynamics, targeting more comfortable and real-world bladder function testing.
DermaSensor announced today that it received Class IIb CE mark approval for its skin cancer detection device.
Karl Storz announced today that it received FDA clearance for the digital, camera-based Rubina Lens exoscope for open surgery.
Three commercially available radiology AI systems have shown the potential to flag early signs of breast cancer up to six years before a diagnosis, according to a study published in Radiology.
A lightweight wearable device developed by UNSW engineers could one day help people monitor their heart and breathing health from home, potentially reducing hospital visits and allowing doctors to detect problems earlier.
Yale researchers have developed a new kind of brain-computer interface (BCI) that lets humans play video games directly with their brains.
Penn Engineers have developed an open-source algorithm that combines the speed of AI with the precision of geometry to compare complex medical images quickly and accurately, helping detect subtle changes that, over time, can signal disease. In some cases, the new algorithm can accomplish in minutes what would have taken prior techniques an entire week.
You go to the hospital for treatment and to get better. But sometimes, you get something much less welcome: an infection.
PARSIPPANY, N.J., June 9, 2026 /PRNewswire/ — Onkos Surgical, a leader in innovative solutions for musculoskeletal oncology and complex orthopaedic conditions, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for the application of its NanoCept Antibacterial Technology on titanium implants within the ELEOS Limb Salvage System.